Orexo Ab Sp/Adr


By |


Orexo AB is a Sweden based pharmaceutical corporation. It is principally engaged in developing pharmaceutical products based on proprietary drug delivery technology. The company's focus is on the segment of opioid dependence and pain but is also intended to address other therapeutic areas. The primary products of the firm are Abstral for the treatment of breakthrough cancer pain; Edluar for the treatment of short-term insomnia; and Zubsolv for the treatment of opioid dependence. The group operates internationally, and Zubsolv generates maximum revenue for the group.

Contact Information

Website: www.orexo.com
Email: beata.augenblick@orexo.com
Main Phone: +46 187808800
Address: Virdings alle 32 A
Address 2: P.O. Box 303
City / Town: Uppsala
Country: SWE
Postal Code: 75105

Issuer Information

Exchange: OTCQX
Employees: 89
$ 6.00 $ 0. (0.00%)
Last Price 6.00 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 6.00
Last Trade Volume 0 52 Wk Hi 8.61 52 Wk Low 3.51
Market Cap 210.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,125,456.00 EPS (TTM) 0.27 PE Ratio 22.60 Exchange OTCQX